These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1717774)

  • 1. Ketanserin in the treatment of peripheral vascular disease or hypertension in patients with diabetes mellitus: a review.
    Janssens M; Symoens J; Robertson MP
    J Cardiovasc Pharmacol; 1991; 17 Suppl 5():S54-66. PubMed ID: 1717774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketanserin in the treatment of diabetic foot ulcer with severe peripheral vascular disease.
    Apelqvist J; Castenfors J; Larsson J; Stenström A; Persson G
    Int Angiol; 1990; 9(2):120-4. PubMed ID: 2254674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketanserin in the treatment of diabetes-associated hypertension.
    Beretta-Piccoli C
    Drugs; 1988; 36 Suppl 1():35-43. PubMed ID: 3071461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketanserin in chronic treatment of hypertension in type 2 diabetes mellitus.
    Fogari R; Zoppi A; Pasotti C; Nicrosini S; Lazzari P; Corradi L
    Int J Clin Pharmacol Ther Toxicol; 1990 May; 28(5):218-22. PubMed ID: 2365539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of action of ketanserin: studies on cardiovascular reactivity in essential and diabetes-associated hypertension.
    Waser M; Ziegler WH; Beretta-Piccoli C
    J Hypertens; 1988 Jun; 6(6):471-9. PubMed ID: 3411125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of ketanserin therapy for the hypertensive diabetic patient.
    Tooke JE; Williams SA
    J Hypertens Suppl; 1989 Dec; 7(6):S318-9. PubMed ID: 2698947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of ketanserin on glucose and lipid metabolism in diabetic patients with hypertension.
    Janka HU; Mehnert H; Fisher R; Seiler KU
    Drugs; 1988; 36 Suppl 1():123-5. PubMed ID: 3240726
    [No Abstract]   [Full Text] [Related]  

  • 8. Low molecular weight heparin seems to improve local capillary circulation and healing of chronic foot ulcers in diabetic patients.
    Jörneskog G; Brismar K; Fagrell B
    Vasa; 1993; 22(2):137-42. PubMed ID: 8391741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of ketanserin on glucose metabolism in hypertensive diabetic subjects].
    Carleo R; Gobbo M; Bonavita M; De Matteo A; Gallo M; Gatti A
    Boll Soc Ital Biol Sper; 1990 Jul; 66(7):639-46. PubMed ID: 1964564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive and metabolic effects of ketanserin in diabetic patients with mild hypertension.
    Beretta-Piccoli C; Salvadé G; Bachmann C; Riesen W; Zuppinger K
    J Hum Hypertens; 1988 Aug; 2(2):103-10. PubMed ID: 3072419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of topical ketanserin in the treatment of skin ulcers: a double-blind study.
    Janssen PA; Janssen H; Cauwenbergh G; De Doncker P; De Beule K; Lewi P; Tytgat HF; Lapière CM
    J Am Acad Dermatol; 1989 Jul; 21(1):85-90. PubMed ID: 2663937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemodynamic and metabolic effects of ketanserin in dyslipidaemic hypertensive subjects.
    Letizia C; Sellini M; Scavo D
    Int J Tissue React; 1991; 13(2):91-3. PubMed ID: 1955297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketanserin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension and peripheral vascular disease.
    Brogden RN; Sorkin EM
    Drugs; 1990 Dec; 40(6):903-49. PubMed ID: 2079001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ketanserin tartrate on serum lipids in patients with essential hypertension.
    Nakamura H; Hirata F; Yasugi T; Mizuno M; Saito E; Ishikawa T; Tada N; Nakaya N; Homma Y; Takeuchi I
    Drugs; 1988; 36 Suppl 1():25-34. PubMed ID: 3071460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized single-blind trial of topical ketanserin for healing acceleration of diabetic foot ulcers.
    Martínez-de Jesús FR; Morales-Guzmán M; Castañeda M; Pérez-Morales A; García-Alonso J; Mendiola-Segura I
    Arch Med Res; 1997; 28(1):95-9. PubMed ID: 9078595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effectiveness of nifedipine in the treatment of arterial hypertension in various types of diabetes mellitus].
    Leowski J; Czech A; Gadomska M; Lastowiecki P; Laz R; Tatoń L
    Pol Tyg Lek; 1990 Feb 5-12; 45(6-7):117-22. PubMed ID: 2216950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of antihypertensive therapy in decreasing renal and cardiovascular complications in diabetes mellitus.
    Nosadini R; Abaterusso C; Dalla Vestra M; Bortoloso E; Saller A; Bruseghin M; Sfriso A; Trevisan M
    Nephrol Dial Transplant; 1998; 13 Suppl 8():44-8. PubMed ID: 9870425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effects of angiotensin-converting enzyme inhibitor on renal function and glucose homeostasis in diabetics with hypertension.
    Ueda Y; Aoi W; Yamachika S; Shikaya T
    Nephron; 1990; 55 Suppl 1():85-9. PubMed ID: 2189076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Healing effect of ketanserin on chronic leg ulcers in patients with diabetes.
    Quatresooz P; Kharfi M; Paquet P; Vroome V; Cauwenbergh G; Piérard GE
    J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):277-81. PubMed ID: 16503887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dalteparin on healing of chronic foot ulcers in diabetic patients with peripheral arterial occlusive disease: a prospective, randomized, double-blind, placebo-controlled study.
    Kalani M; Apelqvist J; Blombäck M; Brismar K; Eliasson B; Eriksson JW; Fagrell B; Hamsten A; Torffvit O; Jörneskog G
    Diabetes Care; 2003 Sep; 26(9):2575-80. PubMed ID: 12941721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.